SCHEMBL5480233

SCHEMBL5480233

Cc1ccccc1-n1c(=O)ccn(Cc2ccc(N)cc2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.43
POLB P06746 1/20 0.40
PDE4D Q08499 2/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
P2RX7 Q99572 1/20 0.39
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 3/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 1/20 0.36
TP53 P04637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP2D6 P10635 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PIK3CD O00329 1/20 0.35
KLKB1 P03952 1/20 0.35
HCAR1 Q9BXC0 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5477811 0.85 HTR6 (0.41) HTR6POLBALDH1A1MAPTKMT2A
SCHEMBL5470634 0.84 LMNA (0.43) HTR6ALDH1A1MAPTKDM4EHTT
SCHEMBL5475973 0.83 ALDH1A1 (0.49) ALDH1A1MAPTKMT2AKDM4ECYP2D6
SCHEMBL5479087 0.79 POLB (0.37) POLBP2RX7ALDH1A1MAPTKMT2A
SCHEMBL5482630 0.73 HPGD (0.49) HTR6ALDH1A1KMT2ACYP2D6
SCHEMBL16881558 0.69 POLB (0.54) HTR6POLBALDH1A1KDM4EKLKB1
SCHEMBL16339690 0.69 JAK2 (0.54) NPC1MAPTTP53KDM4ELMNA
SCHEMBL5474617 0.68 ALDH1A1 (0.61) POLBALDH1A1MAPTKMT2ACYP2D6
Hydrochloric Acid SCHEMBL5474134 0.67 P2RX7 (0.45) P2RX7ALDH1A1LMNA
SCHEMBL7420873 0.67 HPGD (0.62) POLBPDE4DPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010529-A1 Nitrogenous heterocyclic compounds and medical use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010529-A1 Nitrogenous heterocyclic compounds and medical use thereof MAPK1, NOS1, NOS2 HTR6 1538/4885POLB 2709/4885PDE4D 1389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.